Skip to content
WeighLab

Alan Meds vs REMEVi

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Alan Meds has the higher Cost-Efficiency Index: 84/100 versus 82/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Alan Meds
All 50 states
REMEVi
49 states + DC

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Alan Meds

REMEVi

Semaglutide / month
Alan Meds: $99/mo
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
Alan Meds: $145/mo
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Semaglutide / year (modeled)
Alan Meds: $1,188
REMEVi: $2,58713 charges
Tirzepatide / year (modeled)
Alan Meds: $1,740
REMEVi: $3,49713 charges
State availability
Alan Meds: All 50 states
REMEVi: 49 states + DC
Oral / sublingual option listed
Alan Meds: Yes
REMEVi: Yes
Brand-name access listed
Alan Meds: Not confirmed
REMEVi: Not confirmed
Provider facts checked
Alan Meds: See full review
REMEVi: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Alan Meds

Budget-first shoppers who want the lowest sema price plus an oral route nationwide.

Reasons to consider it

  • $99 semaglutide and $145 tirzepatide — among the cheapest disclosed prices we track
  • Nationwide all-50 access with an oral/sublingual option
  • Both molecules published for straightforward cost modeling

What to weigh up

  • Not LegitScript-certified — oversight harder to verify
  • Compounded only — no brand-name access

Regulatory note: the FDA issued a warning letter to Alan Health Technologies Inc. dba Alan in February 2026. We still list and link to Alan Meds; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check Alan Meds pricing Read the full Alan Meds review

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Compounded drugs are not FDA-approved. Understand the medication options.

Check REMEVi pricing Read the full REMEVi review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Alan MedsREMEVi
Normalized Cost/Month
Alan Meds:
94/100
REMEVi:
74/100
Price Transparency
Alan Meds:
79/100
REMEVi:
94/100
Nationwide Access
Alan Meds:
95/100
REMEVi:
86/100
Formulation Options
Alan Meds:
82/100
REMEVi:
77/100
Clinical Oversight
Alan Meds:
76/100
REMEVi:
87/100
Contract Flexibility
Alan Meds:
79/100
REMEVi:
69/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Alan MedsAlternatives to REMEVi
More provider matchups
CoreAge Rx vs Alan MedsCoreAge Rx vs REMEVi
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.